“…Implantation of the PHB-based porous scaffold leads to vigorous vascularization of the scaffold and emergence of islets of the bone tissue newly formed from the granulation tissue in its pores [23, 24, 31]. Evaluation of the expression levels of various cytokines and other markers of inflammation in the implantation site of medical devices based on PHB (and its copolymer PHBV) revealed reduced expression levels of proinflammatory cytokines (interleukins, tumor necrosis factor, monocyte chemoattractant protein, inducible nitric oxide synthase, and C-reactive protein) compared to those for other materials and increased expression of genes encoding various proteins (type I collagen, caveolin-1, cytokeratin, heparan sulfate proteoglycan, thrombomodulin, and prostacycline), which are markers of regenerative processes taking place in cardiac, vascular, intestinal, neural, and osseous tissues [23, 25, 27, 28, 32–35]. However, chronic inflammatory response to the implantation of PHB-based devices (e.g., coronary stent prototypes) was observed in some cases.…”